Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Change in Account Payables (2016 - 2025)

Historic Change in Account Payables for Conmed (CNMD) over the last 16 years, with Q4 2025 value amounting to -$13.6 million.

  • Conmed's Change in Account Payables fell 205379.75% to -$13.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$9.7 million, marking a year-over-year decrease of 16626.11%. This contributed to the annual value of -$9.7 million for FY2025, which is 16626.11% down from last year.
  • According to the latest figures from Q4 2025, Conmed's Change in Account Payables is -$13.6 million, which was down 205379.75% from $5.5 million recorded in Q3 2025.
  • Conmed's Change in Account Payables' 5-year high stood at $13.0 million during Q1 2024, with a 5-year trough of -$13.6 million in Q4 2025.
  • In the last 5 years, Conmed's Change in Account Payables had a median value of $2.4 million in 2023 and averaged $1.9 million.
  • Per our database at Business Quant, Conmed's Change in Account Payables surged by 185836.58% in 2022 and then tumbled by 205379.75% in 2025.
  • Over the past 5 years, Conmed's Change in Account Payables (Quarter) stood at $11.1 million in 2021, then tumbled by 110.56% to -$1.2 million in 2022, then skyrocketed by 672.55% to $6.7 million in 2023, then tumbled by 109.41% to -$632000.0 in 2024, then crashed by 2053.8% to -$13.6 million in 2025.
  • Its Change in Account Payables was -$13.6 million in Q4 2025, compared to $5.5 million in Q3 2025 and $5.7 million in Q2 2025.